Showing results (311-320 of 432) with videos related to

Sort By:
Pageof 44
Leukemia|June 26, 2020
Clonal dominance is an adverse prognostic factor in acute myeloid leukemia treated with intensive chemotherapyMarco Cerrano, Matthieu Duchmann, Rathana Kim, et al.
Haematologica|March 23, 2023
Allogeneic transplantation in acute myelogenous leukemia: a comprehensive single institution's experienceGerard Socie, Jacques-Emmanuel Galimard, Emmanuel Raffoux, et al.
The Lancet. Haematology|August 10, 2025
Oral decitabine and cedazuridine maintenance after haematopoietic stem-cell transplantation in very high-risk acute myeloid leukaemia or myelodysplastic syndrome (GFM-DACORAL-DLI): a multicentre, single-arm, phase 2 trialMarie Robin, Maud D'Aveni, Aspasia Stamatoullas, et al.
Blood|August 28, 2013
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNetLuca Malcovati, Eva Hellström-Lindberg, David Bowen, et al.
Blood|January 28, 2015
An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adultsMichael R Savona, Luca Malcovati, Rami Komrokji, et al.
Blood|April 15, 2025
The ENHANCE-3 study: venetoclax and azacitidine plus magrolimab or placebo for untreated AML unfit for intensive therapyNaval G Daver, Paresh Vyas, Gerwin A Huls, et al.
Blood|July 7, 2022
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELNHartmut Döhner, Andrew H Wei, Frederick R Appelbaum, et al.
The Lancet. Haematology|January 15, 2018
Sotatercept with long-term extension for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes: a phase 2, dose-ranging trialRami Komrokji, Guillermo Garcia-Manero, Lionel Ades, et al.
British Journal of Haematology|April 25, 2015
Validation of the revised international prognostic scoring system (IPSS-R) in patients with lower-risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registryLouise de Swart, Alex Smith, Thomas W Johnston, et al.
Blood|October 14, 2010
Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidineRaphael Itzykson, Sylvain Thépot, Bruno Quesnel, et al.
Pageof 44